Health & Fitness

Daily Briefing

HealthMedicineAlzheimer's DiseaseSanofi-AventisMedicareMentor Corporation

Start your day with the latest health headlines. Each morning, you'll find links to the newest articles on medicine, health and wellness -- the information you need to stay informed.


Drugs widely prescribed to control agitation, aggression, hallucinations or delusions in Alzheimer's patients provided few, if any, benefits and carried severe side effects, according to a large study released Wednesday.

About 270,000 low-income elderly and disabled Californians will be assigned to new Medicare prescription drug plans Jan. 1, raising concern about a resurgence of the coverage glitches that led state officials to bail out the federal program when it was launched this year.

Mentor Withheld Damaging Data on Breast Implants, Group Says

A former scientist at Mentor Corp. accused the company of withholding unfavorable safety data from regulators considering whether to lift 14-year-old limits on silicone breast implants, a consumer group said.

Sanofi-Aventis Vaccine Delivery on Track

Drug developer Sanofi-Aventis said its vaccines business division is on track to deliver 50 million doses of its Fluzone influenza vaccine by the end of November.

Copyright © 2014, Los Angeles Times
Comments
Loading